Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02167685 · ClinicalTrials.gov registry record
The Chimerix CMX001 Registry
A clinical trial, sponsored by Jazz Pharmaceuticals.
- Terminated
- Registry status
- 550
- Enrollment target
NCT02167685: Clinical Trial study, sponsored by Jazz Pharmaceuticals.
NCT02167685 is a clinical trial that was terminated before completion, run by Jazz Pharmaceuticals. The registered enrollment target is 550 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02167685 was terminated before completion, sponsored by Jazz Pharmaceuticals.
- TERMINATED
- Registry status
- 550 participants
- Enrollment target
Study Summary
The prospective observational study is to establish a registry database to evaluate the potential impact of prior treatment with CMX001 on the long-term incidence of specific events, such as outcomes, late CMV and other Double-stranded DNA virus associated events, s well as survival rates in subjects previously enrolled in selected clinical studies of CMX001. Each Registry participant will be followed for a period of approximately 3 years from their enrollment in the Registry.
Primary Outcome
evaluate the potential impact of prior treatment with CMX001 on the long-term incidence of specific events, such as the development of new malignancies and late cytomegalovirus (CMV)-associated events, as well as survival rates in subjects previously enrolled in selected clinical studies of CMX001
Interventions
- DRUG CMX001
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 550 participants |
| Start Date | 2014-01 |
| Est. Completion | 2019-05-10 |
Why NCT02167685 stopped before completion
NCT02167685 is an observational study that tracks outcomes without assigning an intervention. The registered 550 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which CMX001 is the first listed.
NCT02167685 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02167685 about?
NCT02167685 is a clinical study titled "The Chimerix CMX001 Registry". The prospective observational study is to establish a registry database to evaluate the potential impact of prior treatment with CMX001 on the long-term incidence of specific events, such as outcomes, late CMV and other Double-stranded DNA virus associated events, s well as survival rates in subject...
What is the current status of trial NCT02167685?
This trial is currently terminated. The enrollment target is 550 participants. The study started on 2014-01. Estimated completion is 2019-05-10.
What interventions are being tested in trial NCT02167685?
The interventions under investigation include: CMX001 (DRUG).
Who is sponsoring clinical trial NCT02167685?
This trial is sponsored by Jazz Pharmaceuticals, which has 128 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01852448 · 550 participants
Genetics of Insulin and Incretins in Cystic Fibrosis
- NCT02995252 · 550 participants
The HOPE Study: Characterizing Patients With Hepatitis B and C
- NCT03474913 · 550 participants
Upright MRI for Prostate Cancer Screening
- NCT04761120 · 550 participants
Annuloplasty Rings and Band Post-Market Clinical Follow-Up Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia